UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

Biomarker research, 2020-08, Vol.8 (1), p.34-34, Article 34

2020

Volltextzugriff (PDF)

A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1

Genome Biology, 2018-12, Vol.19 (1), p.218-218, Article 218

2018

Volltextzugriff (PDF)

Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy

Journal of experimental & clinical cancer research, 2019-09, Vol.38 (1), p.403-403, Article 403

2019

Volltextzugriff (PDF)

CT-based muscle and adipose measurements predict prognosis in patients with digestive system malignancy

Scientific reports, 2024-06, Vol.14 (1), p.13036-13

2024

Volltextzugriff (PDF)

Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation

Chinese medical journal, 2024-01, Vol.137 (2), p.130-139

2024

Volltextzugriff (PDF)

CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation

Cancers, 2021-04, Vol.13 (8), p.1955

2021

Volltextzugriff (PDF)

Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns

Journal of cancer research and clinical oncology, 2022, Vol.148 (1), p.163-176

2022

Volltextzugriff (PDF)

Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression‐free survival for patients with hepatocellular carcinoma

International journal of cancer, 2014-01, Vol.134 (2), p.342-351

2014

Volltextzugriff (PDF)

An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies

International journal of cancer, 2014-12, Vol.135 (12), p.2783-2794

2014

Volltextzugriff (PDF)

Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells

Current cancer drug targets, 2021-01, Vol.21 (2), p.117-131

2021

Volltextzugriff (PDF)

Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma

Diagnostic pathology, 2018-09, Vol.13 (1), p.72-72, Article 72

2018

Volltextzugriff (PDF)

Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.7762-7771

2023

Volltextzugriff (PDF)

Anti-angiogenesis: Opening a new window for immunotherapy

Life sciences (1973), 2020-10, Vol.258, p.118163-118163, Article 118163

2020

Volltextzugriff (PDF)

Intrathecal pemetrexed combined with involved-field radiotherapy as a first-line intra-CSF therapy for leptomeningeal metastases from solid tumors: a phase I/II study

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920937953-1758835920937953

2020

Volltextzugriff (PDF)

Anti-tumor and immunomodulating activities of a polysaccharide from the root of Sanguisorba officinalis L

International journal of biological macromolecules, 2012-11, Vol.51 (4), p.484-488

2012

Volltextzugriff (PDF)

Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors

Molecular therapy. Nucleic acids, 2018-06, Vol.11 (C), p.23-33

2018

Volltextzugriff (PDF)

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

BMC cancer, 2021-01, Vol.21 (1), p.56-56, Article 56

2021

Volltextzugriff (PDF)

Epigenetic reprogramming reverses the malignant epigenotype of the MMP/TIMP axis genes in tumor cells

International journal of cancer, 2014-04, Vol.134 (7), p.1583-1594

2014

Volltextzugriff (PDF)

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003214

2021

Volltextzugriff (PDF)

Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition

Molecular therapy. Nucleic acids, 2018-09, Vol.12, p.105-117

2018

Volltextzugriff (PDF)

Comment on: “Triceps skinfold‐albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study” by Yin et al. ‐ the authors reply

Journal of cachexia, sarcopenia and muscle, 2023-12, Vol.14 (6), p.2993-2994

2023

Volltextzugriff (PDF)

SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

Journal for immunotherapy of cancer, 2023-02, Vol.11 (2), p.e006055

2023

Volltextzugriff (PDF)

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy

Cancer communications (London, England), 2022-12, Vol.42 (12), p.1331-1346

2022

Volltextzugriff (PDF)

Bmi-1 is critical for the proliferation and invasiveness of gastric carcinoma cells

Journal of gastroenterology and hepatology, 2010-03, Vol.25 (3), p.568-575

2010

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1

Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy

CT-based muscle and adipose measurements predict prognosis in patients with digestive system malignancy

Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation

CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation

Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns

Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression‐free survival for patients with hepatocellular carcinoma

An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies

Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells

Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma

Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients

Anti-angiogenesis: Opening a new window for immunotherapy

Intrathecal pemetrexed combined with involved-field radiotherapy as a first-line intra-CSF therapy for leptomeningeal metastases from solid tumors: a phase I/II study

Anti-tumor and immunomodulating activities of a polysaccharide from the root of Sanguisorba officinalis L

Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

Epigenetic reprogramming reverses the malignant epigenotype of the MMP/TIMP axis genes in tumor cells

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition

Comment on: “Triceps skinfold‐albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study” by Yin et al. ‐ the authors reply

SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy

Bmi-1 is critical for the proliferation and invasiveness of gastric carcinoma cells

Aktive Filter

Suchergebnisse filtern